Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

viatris limited - baclofen 25mg - tablet - 25 mg - active: baclofen 25mg excipient: calcium hydrogen phosphate colloidal silicon dioxide lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

viatris limited - buspirone hydrochloride 10mg;   - tablet - 10 mg - active: buspirone hydrochloride 10mg   excipient: colloidal anhydrous silica lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - buspirone hydrochloride is indicated for the management of anxiety disorders or the short-term relief of symptoms of anxiety with or without accompanying depression. the diagnosis of patients studied in controlled clinical trials of buspirone corresponds to the generalised anxiety disorder of the who classification as described below: generalised, persistent anxiety is manifested by symptoms from three of the following four categories: general tensions: shakiness, jitteriness, jumpiness, trembling, tension, muscle aches, fatigability, inability to relax, eyelid twitch, furrowed brow, strained face, fidgeting, restlessness, easy startle. autonomic hyperactivity: sweating, heart pounding or racing, cold clammy hands, dry mouth, dizziness, lightheadedness, paraesthesias (tingling in hands or feet), upset stomach, hot or cold spells, frequent urination, diarrhoea, discomfort in the pit of the stomach, lump in the throat, flushing, pallor, high resting pulse and respiration rate. apprehensive expectations: anxiety, worry, fear, rumination, and anticipation of misfortune to self or others. vigilance and scanning: hypertensiveness resulting in distractibility, difficulty in concentrating, insomnia, feeling ?on edge?, irritability, impatience. the anxious mood has been continuous for at least one month. the ordinary anxiety and tension associated with the stress of everyday life usually does not require treatment with an anxiolytic agent. controlled clinical studies of buspirone have been limited to six months.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

viatris limited - buspirone hydrochloride 5mg;   - tablet - 5 mg - active: buspirone hydrochloride 5mg   excipient: colloidal anhydrous silica lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - buspirone hydrochloride is indicated for the management of anxiety disorders or the short-term relief of symptoms of anxiety with or without accompanying depression. the diagnosis of patients studied in controlled clinical trials of buspirone corresponds to the generalised anxiety disorder of the who classification as described below: generalised, persistent anxiety is manifested by symptoms from three of the following four categories: general tensions: shakiness, jitteriness, jumpiness, trembling, tension, muscle aches, fatigability, inability to relax, eyelid twitch, furrowed brow, strained face, fidgeting, restlessness, easy startle. autonomic hyperactivity: sweating, heart pounding or racing, cold clammy hands, dry mouth, dizziness, lightheadedness, paraesthesias (tingling in hands or feet), upset stomach, hot or cold spells, frequent urination, diarrhoea, discomfort in the pit of the stomach, lump in the throat, flushing, pallor, high resting pulse and respiration rate. apprehensive expectations: anxiety, worry, fear, rumination, and anticipation of misfortune to self or others. vigilance and scanning: hypertensiveness resulting in distractibility, difficulty in concentrating, insomnia, feeling ?on edge?, irritability, impatience. the anxious mood has been continuous for at least one month. the ordinary anxiety and tension associated with the stress of everyday life usually does not require treatment with an anxiolytic agent. controlled clinical studies of buspirone have been limited to six months.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - prazosin hydrochloride 1.1mg equivalent to 1 mg prazosin - tablet - 1 mg - active: prazosin hydrochloride 1.1mg equivalent to 1 mg prazosin excipient: gelatin lactose monohydrate magnesium stearate maize starch purified talc

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - prazosin hydrochloride 2.2mg equivalent to 2 mg prazosin - tablet - 2 mg - active: prazosin hydrochloride 2.2mg equivalent to 2 mg prazosin excipient: gelatin lactose monohydrate magnesium stearate maize starch purified talc

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - prazosin hydrochloride 5.5mg equivalent to to 5 mg prazosin - tablet - 5 mg - active: prazosin hydrochloride 5.5mg equivalent to to 5 mg prazosin excipient: gelatin lactose monohydrate magnesium stearate maize starch purified talc

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - haloperidol 5 mg/ml - solution for injection - 5 mg/ml - active: haloperidol 5 mg/ml excipient: lactic acid sodium hydroxide water for injection - the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - tamoxifen citrate 15.2mg equivalent to tamoxifen 10 mg - tablet - 10 mg - active: tamoxifen citrate 15.2mg equivalent to tamoxifen 10 mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide magnesium stearate microcrystalline cellulose povidone sodium starch glycolate

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg - tablet - 20 mg - active: tamoxifen citrate 30.4mg equivalent to tamoxifen 20 mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide magnesium stearate microcrystalline cellulose povidone sodium starch glycolate

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - mianserin hydrochloride 30mg - tablet - 30 mg - active: mianserin hydrochloride 30mg excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide hypromellose macrogol 8000 magnesium stearate methylcellulose potato starch titanium dioxide - for relief of symptoms of depression in those cases of depressive illness where drug therapy is indicated.